Bnai Zion Medical center
Haifa, Israel
NCT Number: NCT01116115
The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters in term formula fed infants.
Looking for future studies?
Notify MeUp to 7 day
All sexes
Interventional
Not applicable
Haifa, Israel
InFatTM is an advanced basic-fat ingredient, which mimics the fat composition and properties of human milk fat and enabling optimal intake of the essential calcium and energy (in the form of fatty acids) and easy digestion. These benefits are the result of a unique fatty acid composition on the glycerol backbone, which ensures high level of palmitic acid at the middle (sn-2) position.
The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters, anthropometric parameters and stool characteristics in formula fed term infants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High sn-2 palmitic acid oil based infant formula
Other names: High sn-2 palmitic acid, structured triglyceride
Standard vegetable oil based infant formula
Other names: Standard vegetable oil
Time frame: Baseline, 5 weeks
infant feces microbial analysis
Time frame: Baseline, 5 weeks
Body length, weight, and head circumferences
Time frame: Baseline, 5 weeks
Physical examinations, Health (dieases, doctor visits) and well being (sleeping, crying) questionnaires, medications report
Enzymotec
Industry
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters, Anthropometric Parameters and Stool Characteristics in Term Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05760001
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06690554
Behavior, Disorders of Environmental Origin
Konya, Turkey (Türkiye)
View Trial DetailsNCT07566143
Adherence Interventions, Aging
Van, Turkey (Türkiye)
View Trial DetailsNCT06835920
Behavior, Health Behavior
Chapel Hill, North Carolina, United States
View Trial Details